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The Monetary Cost of Complications After Bypass
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Conclusion: Postoperative complications add large. incremental costs to
CABG surgery. and can be more expensive than the basic direct costs of
the procedure itself. By knowing the incidence and costs of complications,
contract prices can be adjusted to more accurately reflect true direct costs.
Timothy A. Denton, George A. Diamond, Jack M. Matloff. Cedars-Sinai Medical
Center, Los Angeles, Califomia
operation, serum albumin levels of less than 4 mg/dl, low body mass index,
history of congestive heart failure, atrial arrhythmia, cerebral vascular dis-
ease, chronic pulmonary disease, anemia. and blood urea nitrogen levels
greater than 29 mg/dl. A cumulative clinical risk score (CRS) was developed
by assigning each factor a score of 1 to 7 based on the predictive power. The
mean CRS for Groups 1, 2 and 3 were 1.5 ± 4.9, 5.3 ± 3.2 and 9.0 ± 4.5.
respectively (p = 0.0001). The model was prospectively validated on 1235
CAB surgery patients from January 1. 1993 to April 30. 1994. Postoperative
morbidity was stratified by CRS points as low 10-21. moderate (3-5), high (6-
81 and extremely high (::,:9). The validation group morbidity rates fell within
the 95% confidence interval of the predicted rates in each category of risk.
Preoperative patient variables can predict postoperative morbidity for CAB
patients. Significant cost reduction can only be accomplished by reducing
postoperative morbidity. The ability to predict morbidity risk provides data
for improved patient selection and for development of targeted protocols to
reduce specific complications.
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Contract pricing among providers is being used as a method to control the
costs of health care. To estimate a contract price. providers must take into
account not only the direct costs of uncomplicated procedures. but the incre-
mental costs of complications. Accordingly, we determined the incremental
costs of postoperative complications in a series of 722 consecutive patients
(3/12/90 to 3122/94) undergoing routine CABG (DRG 107 - CABG without
catheterization).
We identified 31 prospectively collected candidate variables from the peri-
operative period and 15 routinely collected complications. Total direct costs
were obtained from the hospital central financial system. Only patients who
survived to discharge were included in the analysis. Forward. stepwise. mul-
tiple linear regression was used to determine the incremental costs of com-
plications above the cost of an uncomplicated procedure.
Of the candidate variables. 6 perioperative variables (age, angina CHA
class. non-use of internal thoracic artery, widow(er), peripheral vascular dis-
ease, hypercholesterolemia), and 6 complications contributed to the direct
costs of CABG. The following table shows the incremental cost of each post-
operative complication and its percent of the average direct cost of CABG
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Nowa Omoigui, Joan Booth, Mark Reisman, Irving Franco, Patrick Whitlow,
Multicenter Rotablator Registry. The Cleveland Clinic Foundation, Cleveland, OH
The purpose of this study was to evaluate the success rate, complication pro-
file and predictors of outcome of rotational atherectomy (RA) after guidewire
crossing of chronic total occlusions (CTO). 145 total occlusions were treated
in 139 procedures between 1988 and 1993. Of these, there were 112 sin-
gle lesion procedures. Compared to pts with non-total occlusions (NTOI, pts
with CTO were more likely to be male, younger and have a prior MI, but less
likely to present with unstable angina or to have diabetes. Lesions were more
likely type C (68.7% vs 15.1 %, P < 0.0001) and longer (14.8 ± 7.8 vs 8.0 ±
5.6 mm, p < 0.0001). Mean baseline stenosis was 100.0%. Post-Rotablator
stenosis was 45.6 ± 17.5%. Post-adjunctive balloon stenosis was 24.6 ±
15.9% while final residual stenosis was 26.9 ± 16.8%. The maximum mean
burr size was 1.8 ± 0.26 mm while average vessel diameter was 2.74 ± 0.65
mm. Success without major complications occurred in 91.0%. Dissection
occurred in 18.0%, acute in-lab closure in 3.6%, post-Cath lab reocclusion in
3.6%, emergency bypass surgery on 0%, death in 1.4% and NOMI in 4.3% of
pts. Based on 49.2% angiographic follow-up, restenosis occurred in 62.5%
of pts. Univariate predictors of RA success were pt age (p = 0.02), lesion ec-
centricity (p = 0.04) and vessel diameter (p ~ 0.02). In a multivariable logistic
regression model, only larger vessel diameter remained as an independent
predictor of success (2.8 ± 0.6 vs 2.0 ± 0.5 mm). Older age (p ~ 0.04) and
diabetes (p ~ 0.01) were univariate predictors of restenosis. However, in the
final multivariable logistic model, only diabetes remained a significant pre-
dictor.
In conclusion, RA for the treatment of CTO has acceptable success and
restenosis. Non-diabetics with relatively larger vessel diameter appear to
benefit most.
There were significant correlations of B/A ratio (p = 0.051 and OS after
MRA (p ~ 0.01) with lower final OS.
Conclusions: For Rotablator, final burr/artery ratio >0.7 resulted in signifi-
cantly better luminal enlargement compared to burr/artery ratio <0.7 and did
not lead to increased major clinical and angiographic complications. These
data should be evaluated in larger prospective randomized trials.
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In an effort to identify areas of high cost for coronary artery bypass (CAB)
surgery. we used logistic regression methods to predict patients at risk for
postoperative morbidity. The predictive model was derived from 1567 con-
secutive isolated CAB cases performed between July 1, 1991 and Decem-
ber 31, 1992. The patients were categorized into 3 groups: Group 1 IN =
756,48%) no complications, Group 2 (N = 560, 36%) minor complications,
and Group 3 (N = 251, 16%) major complications with extended stay and/or
death. Estimated hospital costs were 3.5 times higher for Group 3 than
Group 1, and 2 times higher for Group 2 than Group 1. The following patient
factors were found to be significant independent predictors of morbidity,
listed in decreasing order of importance: preoperative cardiogenic shock,
emergency surgery, severe left ventricular dysfunction, cardiac laboratory
induced cardiac collapse, increasing age, diabetes mellitus, high serum cre-
atinine levels, peripheral vascular disease, cardiomegaly, female gender, re-
Curtis A. Prejean, Guo-Wen Sun, Manuel R. Estioko. Gregory L. Kay. The Heart
Institute, The Good Samaritan Hospital, Los Angeles. California
Influence of risk factors on cerebrovascular accidents (CVA) in cardiac
surgery has been investigated in several studies, but no one has identified
differences in risk factors on intraoperative CVA (I-CVA) and postoperative
CVA (P-CVA). I-CVA is identified when evidence of CVA is seen as patient
emerges from anesthesia and P-CVA is identified if after emerging from
anesthesia normally, signs of CVA then appear. To explore proper preventive
strategies for each CVA. data were reviewed in 4351 adult patients who un-
derwent cardiac surgery between 1/1/90 and 6/30194. Sixty (1.38%) patients
suffered I-CVA and 53 (1.24%) patients experienced P-CVA. CVA patients are
older (I-CVA: 69.6 vs. 64.2, p < 0.001; P-CVA: 70.1 vs. 64.1, P < 0.001) and
I-CVA shows a higher proportion of females (45.0% vs. 30.0%. p ~ 0.01).
The rates of I-CVA and P-CVA are 1.48% and 1.34% for isolated CABG pa-
tients (n = 3037). 0.28% and 0.70% for isolated valve patients (n = 713).
1.90% and 1.69% for patients who undervvent combined procedures (n =
422),2.79% and 0.57% for other surgeries (n = 179). Patient age (p < 0.001)
and proportion of females (p < 0.0011 differed by procedures (CABG: 64.6 ±
10.4.25.0%; Valve: 60.4 ± 15.7.46.1 %; CABG + Valve: 704 ± 9.0, 34.8%;
others: 58.4 ± 16.2.44.7%). In order to adjust influence of preoperative risk
factors on each CVA. stepwise logistic regression was applied to a subset
of isolated CABGs.
Influence of Preoperative Risk Factors on
Intraoperative and Postoperative
Cerebrovascular Accidents in Cardiac Surgery
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A Prospective Clinical Risk Score for Predicting
Morbidity After Coronary Artery Bypass Surgery
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Conclusions: (1) The risk of I-CVA or P-CVA is higher for CABG procedures,
with or without associated valve procedure, than for isolated valve proce-
dures. (2) Patient age is a predictor for I-CVA and P-CVA. (3) There may be a
slightly increased risk for I-CVA in females.
Culprit Lesion None Graft Native Vessel
n (pts.) 15(11.8%) 66 (52.0%) 46(362%)
Age [baseline angiol (yrs) 65.5 (53-76)' 59B (45-73)' 604 (36-74)
Male gender 1'101 80 90.9 869
Time CABG-interim angio (mo) 77.1 ± 10 1026 ± 3.2' 90.3±5.1·'
Resultant PTCNCABG 1%) 010 33.3/31.8 304143
Indobufen Versus ASA + Dipyridamole on
Coronary Artery Bypass Graft Patency:
Combined Analysis of Two Multicenter Trials
Gabriella Cataldo, S.M. Rajah, SINBA and UK Indobufen Multicenter Study.
Department of Cardiology, Niguarda Hospital. Milan, Italy
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Two prospective randomized double blind clinical trials, performed in United
Kingdom IUKI and in Italy (IT) showed that Indobufen IINB reversible cy-
clooxygenase inhibitorl is as effective as, and safer than, the association of
Aspirin plus Dipyridamole in preventing the occlusion of saphenous vein (SV)
coronary artery bypass grafts (CABG).
The power of each of the two trials was 80% for a difference in graft occlu-
sion of 10%. We present the results of the analysis, carried out by properly
combining the information given by the two trials in order to increase the
precision of the estimates both of efficacy and of safety. The analysis was
performed on total 934 patients who undervvent 1 year angiography (2258
SV distal anastomosis).
UK and IT patients had similar clinical characteristics, UK pts had higher
number of grafts per patient and smaller vessel diameters, distal anastomo-
sis occlusion rates were 19.8% (UK) and 20.9% (IT), small vessel diameter
«1.5 mm) and right coronary artery location adversely affected graft patency
in both groups.
Combined analysis showed that: al the Odds Ratio of distal anastomosis
occlusion of INB vs ASA + DIP group is: OR = 1.05 (95% CL: 0.85 - 1.291
suggesting that the efficacy of the two treatments is comparable and b) INB
had significantly fewer side effects than ASA + DIP.
Conclusions
- two multicenter CABG studies performed in different countries accruing
patients with similar clinical characteristics showed similar graft patency;
- combined analysis confirmed on a wide population that IN B is as effec-
tive as the association of ASA + DIP on graft patency and is much better
tolerated.
OM in M were: age> 70 (2.71. LVEF < 40% (2.6), OM (1.61, PVD (2.3), SMa
(1.9), renal failure (2.5), PMI (2.0) and for F the predictors were: age> 70 (2.0),
US (2.51. LV grade (3.2), PVD (2.8). The predictors of LOS in M were: age>
70 (1.6), LVEF < 40% (2.2). REDO (5.6), left main LMS (1.3), endarterectomy
EA (1.81. OM (1.6). congestive failure (2.1), PMI (2.0). LOS predictors for F
were: US (1.6), LVEF < 40% 12.5). LMS 11.71, REDO (4.2). EA (3.21.
Conclusion: Risk factors for OM and LOS were similar for males and fe-
males. Increased risk of surgery for Fmay be related to differences in method
of atherosclerosis development.
Analysis of the Culprit Lesion and Clinical Events
in Post-CABG Patients: Interim Angiographic
Results from the Post-CABG Trial
Intraoperative eVA Postoperative eVA
Risk Factor Odds Ratio p Risk Factor Odds Ratio p
Carotid Disease 481 <0.001 Prior Stroke 7.33 <0.001
Renal Disease 4.04 <0.001 Refuse blood 6.68 0003
Diabetes 262 0.003 Cardiac Arrest 6.60 <0.001
MI S 30 Days 2.50 0.103 Carotid Disease 361 0.012
Age 20 65 Years 191 0.074 Cardiogenic Shock 302 0.014
Female Gender 180 0.063 Age> 75 Years 2.05 0.041
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Clinical events prompting angiography occur in patients post bypass surgery,
and often necessitate repeat revascularization procedures. In these patients
the culprit lesion may occur in either the native vessel or the graft. The Post-
CABG study, a 5 year trial aimed at reducing SVG closure in minimally symp-
tomatic patients 1-11 years Post-CABG, offers a unique view into this prob-
lem, since this study requires an initial angiogram to document baseline graft
patency. In a subgroup of Post-CABG patients in whom symptoms prompted
an interim "clinically driven" angiogram, we compared the baseline and in-
terim angiograms for the presence or absence of a culprit lesion defined as
total occlusion, angiographic clot, lesion change :::50% or lesion>75% di-
ameter stenosis. Of 1253 enrolled patients with at least one SVG patent, 127
patients with clinical events and analyzable interim angiograms were evalu-
ated.
Results:
* none vs native vessel. t none vs graft, ** graft vs native vessel, p < 0.05
George T. Christakis, Karen Buth, Richard D. Weisel, Vivek Rao, Joan Ivanov,
Stephen E. Fremes. University of Toronto, Toronto, Ontario, Canada
Clinical indications for angiography differed depending on the anatomic
site of the culprit lesioR. Patients with graft culprit lesions more frequently
had MI (30.8%) than patients with culprit native vessel lesions (11.1 %) P <
0.05, or with no lesions (0%).
Conclusions: In Post-CABG patients with clinical events that necessitated
repeat angiography, only one-half had graft disease as the identifiable cause.
No responsible lesion was found in 12%. Treatment for symptomatic pa-
tients fOllowing coronary artery bypass surgery may differ substantially de-
pending on the anatomic cause of symptoms.
Females (F) present for CABG with a different demographic profile than
males (M) and have a higher incidence of mortality (OM) and low output syn-
drome (LOS). Females may not have the same predictors of OM and LOS as
males. This study was designed to assess the determinants of OM and LOS
for F and M proceeding to isolated CABG. Between 1990 and 1994 pre and
perioperative data were prospectively collected on 7,633 CABG patients (M
= 6168, F = 1465). Differences in preoperative risk variables between M and
F were assessed by univariate statistics. The fOllowing were significant (p <
0.05) gender differences: F were older (F = 64 ± 9, M = 60 ± 9). and had a
higher incidence of urgent surgery US (F = 22%, M = 14%). class IV symp-
toms (F = 53%, M = 36%), preoperative myocardial infarction PMI (F = 18%,
M = 14%, p = 0.001), diabetes OM (F = 31 %, M = 20%). hypertension (F =
62%, M = 46%). peripheral vascular disease PVD IF = 15%, M = 12%, P =
0.002). hypercholesterolemia (F = 57%, M = 51 %), smoking history SMa IF
= 52%, M = 77%). preoperative strokes (F = 9%, M ~ 6%, p = 0.001), sin-
gle vessel disease (F = 9%, M = 5%). left ventricular ejection fraction (LVEFI
>40% (F ~ 83%, M = 78%). Females had a lower incidence of reoperative
surgery REDO (F = 3.6%, M = 6.6%1. Postoperatively F had a higher (p <
0.001) incidence of OM (F = 3.5%, M = 1.8%). LOS (F = 15%, M = 6.6%),
and MIIF = 5.5%, M = 2.8%). The multivariable risk factors (odds ratios) for
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In terms of hospital rankings, there was generally close correlation be-
tween any two of the methods (Spearman's R = 0.87,0.88, and 0.93, com-
paring P-O, P-H, and H-O). Rankings for an individual hospital varied, how-
ever, an average of ±3.3 ranks (range 0-12 ranks) depending on which risk-
adjustment methodology was used.
Conclusion: In general. published methods of risk-adjustment for bypass
surgery accurately identify institutions with low, moderate and high adjusted
Health care payors and consumers have a growing interest in risk-adjusted
provider profiles. Using chart-abstracted clinical data from the Cooperative
Cardiovascular Project. we ranked 28 hospitals performing bypass surgery
in Alabama and Iowa by their risk-adjusted surgical mortality rates using
three published risk-adjustment methodologies: Parsonnet (PI, O'Connor (a)
and Hannan (H). In total. 3653 bypass surgery cases performed from 6/92
to 3/93 were reviewed (mean 130 cases/hospital). The discriminatory abili-
ties of each method for predicting surgical mortality were quite similar (area
under ROC curves 0.72-0.75). Below, we display the risk-adjusted hospital
rankings (comparing observed with expected mortality) by these three risk-
adjustment techniques:
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Do Females have the Same Risk Factors as Males
for CABG?
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